Whole Body Dynamic 68Ga-DOTATOC PET/CT in Neuroendocrine Tumors

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

July 19, 2018

Primary Completion Date

July 6, 2023

Study Completion Date

July 6, 2023

Conditions
Neuroendocrine Tumors
Interventions
DEVICE

Whole Body Dynamic 68Ga-DOTATOC PET/CT

"68Ga-DOTATOC PET-CT will be performed in the nuclear medicine department of the University Hospital of Brest on a Biograph mCT S64 machine (Siemens medical, Erlangen, Germany) Time of Flight system after intravenous injection of 150MBq of 68Ga-DOTATOC. In the usual conditions for performing this exam, the patient must remain at a strict rest for 60 minutes following the injection of the tracer and before a static 3D acquisition. For this protocol, a complementary 4D dynamic acquisition (15-60 minutes post-injection) will be performed during this usual rest period."

Trial Locations (1)

29609

CHRU de Brest, Brest

All Listed Sponsors
lead

University Hospital, Brest

OTHER

NCT03576040 - Whole Body Dynamic 68Ga-DOTATOC PET/CT in Neuroendocrine Tumors | Biotech Hunter | Biotech Hunter